<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34138401</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1573-7322</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
            </PubDate>
          </JournalIssue>
          <Title>Heart failure reviews</Title>
          <ISOAbbreviation>Heart Fail Rev</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Peripartum cardiomyopathy: a review.</ArticleTitle>
        <Pagination>
          <StartPage>1287</StartPage>
          <EndPage>1296</EndPage>
          <MedlinePgn>1287-1296</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10741-020-10061-x</ELocationID>
        <Abstract>
          <AbstractText>Peripartum cardiomyopathy is a form of idiopathic systolic heart failure which occurs during the end of pregnancy or the early post-partum in the absence of an identifiable etiology. The exact pathogenesis remains unknown, and the incidence is higher in African ancestry, multiparous and hypertensive women, or older maternal age. Delay in diagnosis is common, mainly because symptoms of heart failure mimic those of normal pregnancy. Echocardiography showing decreased myocardial function is at the center of the diagnosis. Management relies on the general guidelines of management of other forms of non-ischemic cardiomyopathy; however, special attention should be paid when choosing medications to ensure fetal safety. Outcomes can be variable and can range from complete recovery to persistent heart failure requiring transplant or even death. High rates of relapse with subsequent pregnancies can occur, especially with incomplete myocardial recovery. Additional research about the etiology, experimental drugs, prognosis, and duration of treatment after recovery are needed.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Iorgoveanu</LastName>
            <ForeName>Corina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, IA, 52242, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zaghloul</LastName>
            <ForeName>Ahmed</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, IA, 52242, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ashwath</LastName>
            <ForeName>Mahi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, IA, 52242, USA. mahi-ashwath@uiowa.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>17</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Heart Fail Rev</MedlineTA>
        <NlmUniqueID>9612481</NlmUniqueID>
        <ISSNLinking>1382-4147</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058725" MajorTopicYN="N">Peripartum Period</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011644" MajorTopicYN="Y">Puerperal Disorders</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Heart failure</Keyword>
        <Keyword MajorTopicYN="Y">Peripartum cardiomyopathy</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>11</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>17</Day>
          <Hour>12</Hour>
          <Minute>56</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34138401</ArticleId>
        <ArticleId IdType="pmc">PMC8510921</ArticleId>
        <ArticleId IdType="doi">10.1007/s10741-020-10061-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s10741-020-10061-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ritchie C. Clinical contributions to the pathology, diagnosis, and treatment of certain chronic diseases of the heart. Edinb Med Surg J. 1849;72(181):325–339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5792849</ArticleId>
            <ArticleId IdType="pubmed">30330805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hull EHF. Toxic postpartum heart disease. New Orleans Med Surg J. 1937;89:550–557.</Citation>
        </Reference>
        <Reference>
          <Citation>Bauersachs J, König T, van der Meer P, et al.  Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827–843. doi: 10.1002/ejhf.1493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.1493</ArticleId>
            <ArticleId IdType="pubmed">31243866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–778. doi: 10.1093/eurjhf/hfq120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurjhf/hfq120</ArticleId>
            <ArticleId IdType="pubmed">20675664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stergiopoulos K, Lima FV. Peripartum cardiomyopathy-diagnosis, management, and long term implications. Trends Cardiovasc Med. 2019;29(3):164–173. doi: 10.1016/j.tcm.2018.07.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcm.2018.07.012</ArticleId>
            <ArticleId IdType="pubmed">30111492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irizarry OC, Levine LD, Lewey J, et al.  Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American Women. JAMA Cardiol. 2017;2(11):1256–1260. doi: 10.1001/jamacardio.2017.3574.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamacardio.2017.3574</ArticleId>
            <ArticleId IdType="pmc">PMC5815055</ArticleId>
            <ArticleId IdType="pubmed">29049825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuklina EV, Callaghan WM. Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004–2006. Obstet Gynecol. 2010;115(1):93–100. doi: 10.1097/AOG.0b013e3181c4ee8c.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0b013e3181c4ee8c</ArticleId>
            <ArticleId IdType="pubmed">20027040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolte D, Khera S, Aronow WS, et al.  Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3(3):e001056. doi: 10.1161/JAHA.114.001056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.114.001056</ArticleId>
            <ArticleId IdType="pmc">PMC4309108</ArticleId>
            <ArticleId IdType="pubmed">24901108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pearson GD, Veille JC, Rahimtoola S, et al.  Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283(9):1183–1188. doi: 10.1001/jama.283.9.1183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.283.9.1183</ArticleId>
            <ArticleId IdType="pubmed">10703781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharyya A, Basra SS, Sen P, Kar B. Peripartum cardiomyopathy: a review. Tex Heart Inst J. 2012;39(1):8–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3298938</ArticleId>
            <ArticleId IdType="pubmed">22412221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson JL, Horne BD. Birthing the genetics of peripartum cardiomyopathy. Circulation. 2010;121(20):2157–2159. doi: 10.1161/CIRCULATIONAHA.110.956169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.110.956169</ArticleId>
            <ArticleId IdType="pubmed">20458008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ricke-Hoch M, Pfeffer TJ, Hilfiker-Kleiner D. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies. Cardiovasc Res. 2020;116(3):520–531. doi: 10.1093/cvr/cvz252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/cvz252</ArticleId>
            <ArticleId IdType="pubmed">31605117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negoro S, Kunisada K, Fujio Y, et al.  Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation. 2001;104(9):979–981. doi: 10.1161/hc3401.095947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/hc3401.095947</ArticleId>
            <ArticleId IdType="pubmed">11524388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005;193(2):363–365. doi: 10.1016/j.ajog.2005.01.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajog.2005.01.022</ArticleId>
            <ArticleId IdType="pubmed">16098856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol. 2007;118(1):14–20. doi: 10.1016/j.ijcard.2006.04.090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2006.04.090</ArticleId>
            <ArticleId IdType="pubmed">16904777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tak BT, Cay S, Pamukcu HE, et al.  Prognostic nutritional index as a novel marker for prediction of prognosis in patients with peripartum cardiomyopathy. Medicine (Baltimore) 2020;99(11):e19524. doi: 10.1097/MD.0000000000019524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000019524</ArticleId>
            <ArticleId IdType="pmc">PMC7440167</ArticleId>
            <ArticleId IdType="pubmed">32176104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierce JA, Price BO, Joyce JW. Familial occurrence of postpartal heart failure. Arch Intern Med. 1963;111:651–655. doi: 10.1001/archinte.1963.03620290117016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archinte.1963.03620290117016</ArticleId>
            <ArticleId IdType="pubmed">13943404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morales A, Painter T, Li R, et al.  Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation. 2010;121(20):2176–2182. doi: 10.1161/CIRCULATIONAHA.109.931220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.931220</ArticleId>
            <ArticleId IdType="pmc">PMC2900861</ArticleId>
            <ArticleId IdType="pubmed">20458009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP, et al.  Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014;35(32):2165–2173. doi: 10.1093/eurheartj/ehu050.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehu050</ArticleId>
            <ArticleId IdType="pubmed">24558114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ware JS, Li J, Mazaika E, et al.  Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med. 2016;374(3):233–241. doi: 10.1056/NEJMoa1505517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1505517</ArticleId>
            <ArticleId IdType="pmc">PMC4797319</ArticleId>
            <ArticleId IdType="pubmed">26735901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herman DS, Lam L, Taylor MR, et al.  Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366(7):619–628. doi: 10.1056/NEJMoa1110186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1110186</ArticleId>
            <ArticleId IdType="pmc">PMC3660031</ArticleId>
            <ArticleId IdType="pubmed">22335739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol (Oxf) 2002;57(5):609–613. doi: 10.1046/j.1365-2265.2002.01638.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2265.2002.01638.x</ArticleId>
            <ArticleId IdType="pubmed">12390334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11(6):364–370. doi: 10.1038/nrcardio.2014.37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrcardio.2014.37</ArticleId>
            <ArticleId IdType="pubmed">24686946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honigberg MC, Givertz MM. Peripartum cardiomyopathy. BMJ. 2019;364:k5287. doi: 10.1136/bmj.k5287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.k5287</ArticleId>
            <ArticleId IdType="pubmed">30700415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim MJ, Shin MS. Practicalmanagementofperipartumcardiomyopathy. Korean J Intern Med. 2017;32(3):393–403. doi: 10.3904/kjim.2016.360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3904/kjim.2016.360</ArticleId>
            <ArticleId IdType="pmc">PMC5432806</ArticleId>
            <ArticleId IdType="pubmed">28407464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ballo P, Betti I, Mangialavori G, Chiodi L, Rapisardi G, Zuppiroli A. Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine. Case Rep Med. 2012;2012:476903. doi: 10.1155/2012/476903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/476903</ArticleId>
            <ArticleId IdType="pmc">PMC3521613</ArticleId>
            <ArticleId IdType="pubmed">23251175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haghikia A, Podewski E, Libhaber E, et al.  Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108(4):366. doi: 10.1007/s00395-013-0366-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00395-013-0366-9</ArticleId>
            <ArticleId IdType="pmc">PMC3709080</ArticleId>
            <ArticleId IdType="pubmed">23812247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2002;4(3):305–309. doi: 10.1016/S1388-9842(02)00008-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1388-9842(02)00008-9</ArticleId>
            <ArticleId IdType="pubmed">12034156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McTiernan CF, Morel P, Cooper LT, et al.  Circulating T-cell subsets, monocytes, and natural killer cells in peripartum cardiomyopathy: results from the multicenter IPAC study. J Card Fail. 2018;24(1):33–42. doi: 10.1016/j.cardfail.2017.10.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cardfail.2017.10.012</ArticleId>
            <ArticleId IdType="pmc">PMC6467571</ArticleId>
            <ArticleId IdType="pubmed">29079307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goulet B, McMillan T, Bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerpernium. Am J Med Sci. 1937;194(2):185–199. doi: 10.1097/00000441-193708000-00005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000441-193708000-00005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kara RJ, Bolli P, Karakikes I, et al.  Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res. 2012;110(1):82–93. doi: 10.1161/CIRCRESAHA.111.249037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.111.249037</ArticleId>
            <ArticleId IdType="pmc">PMC3365532</ArticleId>
            <ArticleId IdType="pubmed">22082491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Demakis JG, Rahimtoola SH, Sutton GC, et al.  Naturalcourseofperipartumcardiomyopathy. Circulation. 1971;44(6):1053–1061. doi: 10.1161/01.CIR.44.6.1053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.CIR.44.6.1053</ArticleId>
            <ArticleId IdType="pubmed">4256828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brar SS, Khan SS, Sandhu GK, et al.  Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100(2):302–304. doi: 10.1016/j.amjcard.2007.02.092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjcard.2007.02.092</ArticleId>
            <ArticleId IdType="pubmed">17631087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cénac A, Simonoff M, Moretto P, Djibo A. Alowplasmaseleniumisariskfactorforperipartum cardiomyopathy A comparative study in Sahelian Africa. Int J Cardiol. 1992;36(1):57–59. doi: 10.1016/0167-5273(92)90108-F.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0167-5273(92)90108-F</ArticleId>
            <ArticleId IdType="pubmed">1428253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fett JD, Sundstrom BJ, Etta King M, Ansari AA. Mother-daughter peripartum cardiomyopathy. Int J Cardiol. 2002;86(2–3):331–332. doi: 10.1016/S0167-5273(02)00357-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0167-5273(02)00357-1</ArticleId>
            <ArticleId IdType="pubmed">12419575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel PA, Roy A, Javid R, Dalton JA. A contemporary review of peripartum cardiomyopathy.  Clin Med (Lond) 2017;17(4):316–321. doi: 10.7861/clinmedicine.17-4-316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7861/clinmedicine.17-4-316</ArticleId>
            <ArticleId IdType="pmc">PMC6297639</ArticleId>
            <ArticleId IdType="pubmed">28765406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum Cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(2):207–221. doi: 10.1016/j.jacc.2019.11.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2019.11.014</ArticleId>
            <ArticleId IdType="pubmed">31948651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Petrie MC, van der Meer P, et al. (2020) Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry Eur Heart J 41(39):3787–3797 (In eng)</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7846090</ArticleId>
            <ArticleId IdType="pubmed">32840318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154(1):27–31. doi: 10.1016/j.ijcard.2010.08.065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijcard.2010.08.065</ArticleId>
            <ArticleId IdType="pubmed">20863583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felker M, Mann D (2020) A companion to Braunwald's heart disease. Heart failure Vol Fourth Volume Elsevier inc.</Citation>
        </Reference>
        <Reference>
          <Citation>Rodriguez Ziccardi M, Siddique MS (2001) Peripartum cardiomyopathy, StatPearls Publishing, 2020 Drugs AAoPCo.Transfer of drugs and other chemicals into human milk.Pediatrics 108:776–89</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11533352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:457–476. doi: 10.1016/j.jacc.2018.10.075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2018.10.075</ArticleId>
            <ArticleId IdType="pubmed">30704579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al.  ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur Heart J. 2011;32(24):3147–3197. doi: 10.1093/eurheartj/ehr272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehr272</ArticleId>
            <ArticleId IdType="pubmed">21873418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasmusson K, Brunisholz K, Budge D, et al.  Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant. 2012;31:180–186. doi: 10.1016/j.healun.2011.11.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.healun.2011.11.018</ArticleId>
            <ArticleId IdType="pubmed">22305380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindley K, Verma V, Blauwet L. Peripartum cardiomyopathy. Heart Failure Clinics. 2019;15(1):29–39. doi: 10.1016/j.hfc.2018.08.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.hfc.2018.08.004</ArticleId>
            <ArticleId IdType="pubmed">30449378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Blauwet L, Tibazarwa K, et al (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121(13):1465-73. 10.1161/CIRCULATIONAHA.109.901496</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20308616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yameogo NV, Kagambega LJ, Seghda A, et al (2017) Bromocriptine in management of peripartum cardiomyopathy: A randomized study on 96 women in Burkina Faso. J Cardiol Clin Res 5:1098</Citation>
        </Reference>
        <Reference>
          <Citation>Hilfiker-Kleiner D, Haghikia A, Berliner D, et al (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38(35):2671-2679. 10.1093/eurheartj/ehx355</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5837241</ArticleId>
            <ArticleId IdType="pubmed">28934837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mason JW, O'Connell JB, Herskowitz A, et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis The Myocarditis Treatment Trial Investigators N Engl J Med 333(5):269–275</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7596370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs AAoPCo (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108(3):776–789</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11533352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McNamara DM, Elkayam U, Alharethi R, et al.  Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy- Associated Cardiomyopathy) J Am Coll Cardiol. 2015;66(8):905–914. doi: 10.1016/j.jacc.2015.06.1309.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jacc.2015.06.1309</ArticleId>
            <ArticleId IdType="pmc">PMC5645077</ArticleId>
            <ArticleId IdType="pubmed">26293760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habli M, O'Brien T, Nowack E, Khoury S, Barton JR, Sibai B. Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol. 2008;199(4):415.e411–415.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18722572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moioli M, Valenzano Menada M, Bentivoglio G, Ferrero S. Peripartum cardiomyopathy. Arch Gynecol Obstet. 2010;281(2):183–188. doi: 10.1007/s00404-009-1170-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-009-1170-5</ArticleId>
            <ArticleId IdType="pubmed">19655159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elkayam U, Schäfer A, Chieffo A, et al. (2019) Use of Impella heart pump for management of women with peripartum cardiogenic shock Clin Cardiol 2019;42(10):974–981 (In eng) 10.1002/clc.23249</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/clc.23249</ArticleId>
            <ArticleId IdType="pmc">PMC6788473</ArticleId>
            <ArticleId IdType="pubmed">31436333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sieweke JT, Pfeffer TJ, Berliner D, et al. (2020) Cardiogenic shock complicating peripartum cardiomyopathy: importance of early left ventricular unloading and bromocriptine therapy Eur Heart J Acute Cardiovasc Care 9(2):173–182 (In eng) 10.1177/2048872618777876</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2048872618777876</ArticleId>
            <ArticleId IdType="pubmed">29792513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sliwa K, Petrie MC, Hilfiker-Kleiner D, et al. (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy Eur J Heart Fail 20(6):951–962 (In eng) 
10.1002/ejhf.1178</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.1178</ArticleId>
            <ArticleId IdType="pubmed">29578284</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
